GB201319165D0 - New disease modifying therapy of neurodegenerative diseases - Google Patents
New disease modifying therapy of neurodegenerative diseasesInfo
- Publication number
- GB201319165D0 GB201319165D0 GB201319165A GB201319165A GB201319165D0 GB 201319165 D0 GB201319165 D0 GB 201319165D0 GB 201319165 A GB201319165 A GB 201319165A GB 201319165 A GB201319165 A GB 201319165A GB 201319165 D0 GB201319165 D0 GB 201319165D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- neurodegenerative diseases
- disease modifying
- new disease
- modifying therapy
- therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201319165A GB201319165D0 (en) | 2013-10-30 | 2013-10-30 | New disease modifying therapy of neurodegenerative diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201319165A GB201319165D0 (en) | 2013-10-30 | 2013-10-30 | New disease modifying therapy of neurodegenerative diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201319165D0 true GB201319165D0 (en) | 2013-12-11 |
Family
ID=49767387
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB201319165A Ceased GB201319165D0 (en) | 2013-10-30 | 2013-10-30 | New disease modifying therapy of neurodegenerative diseases |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201319165D0 (en) |
-
2013
- 2013-10-30 GB GB201319165A patent/GB201319165D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL274646A (en) | Integrated continuous manufacturing of therapeutic protein drug substances | |
IL287516A (en) | Therapeutic uses of empagliflozin | |
HRP20190101T1 (en) | Therapeutic uses of empagliflozin | |
HK1213818A1 (en) | Therapeutic uses of empagliflozin | |
SI3626270T1 (en) | Treatment of cardiovascular diseases | |
EP2968321A4 (en) | Compounds for treatment of fibrosis diseases | |
SI2981271T1 (en) | Therapeutic uses of empagliflozin | |
EP2943189A4 (en) | Methods and comp0stions for treatment of demyelinating diseases | |
EP2906583A4 (en) | Peptides for the treatment of neurodegenerative diseases | |
EP2974730A4 (en) | Drug for respiratory diseases | |
ZA201603117B (en) | Withanolides useful for the treatment of neurodegenerative diseases | |
GB2516137B (en) | The local treatment of inflammatory ophthalmic diseases | |
IL243637A0 (en) | Ppar-sparing compounds for the treatment of metabolic diseases | |
HK1220127A1 (en) | Treatment of autoimmune diseases | |
EP2949329A4 (en) | Therapeutic agent for demyelinating disease | |
GB201319165D0 (en) | New disease modifying therapy of neurodegenerative diseases | |
GB201321628D0 (en) | Treatment of disease | |
IL241331B (en) | Inhibition of neurodegenerative disease | |
GB201306413D0 (en) | The local treatment of ophthalmic diseases | |
GB201305638D0 (en) | Changing the expression profile of neurons to treat neurodegenerative diseases | |
GB201301072D0 (en) | Therapeutic Moisturiser | |
GB201300778D0 (en) | Therapeutic moisturiser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |